Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 24, 2014
- Accepted in final form December 1, 2014
- First Published January 22, 2015.
Author Disclosures
- Scott S. Zamvil, MD, PhD and
- Anthony J. Slavin, PhD
- Scott S. Zamvil, MD, PhD and
Dr. Zamvil has received honoraria for serving on Data Safety Monitoring Boards for MS trials conducted by BioMS, Teva Pharmaceuticals, Inc. and Eli Lilly and Co.
NONE
NONE
(1) Neurology, Neuroimmunology and Neuroinflammation, Associate Editor, 2011-present (2) Journal the Neurological Sciences, Associate Editor, 2011-present
“Aquaporin-4 peptides and methods for using same” (SF2010-074; USF-461PRV (pending). The application describes the discovery of aquaporin-4 T cell determinants in neuromyelitis optica patients and the use for antigen-specific tolerance.
NONE
SSZ has received honoraria for speaking engagements for Biogen-Idec, Teva-Neuroscience, and Genzyme.
SSZ has served as a consultant to Biogen Idec, Teva Neuroscience, EMD-Serono, Genzyme and Novartis
Advanced Health Media, 2009-present Biogen Idec, 2009-present
NONE
NONE
NONE
NIH RO1 AI073737 NIH RO1 NS 063008
NMSS RG 4768A9/1 NMSS RG 5180A11/1
Guthy Jackson Charitable Foundation, PI Alexander M. and June L. Maisin Foundation, PI
NONE
NONE
NONE
NONE
NONE
NONE
- Anthony J. Slavin, PhD
NONE
NONE
NONE
NONE
NONE
NONE
Anthony Slavin is currently an employee of Abbvie Bioresearch Center and was formerly an employee of Boehringer Ingelheim Pharmaceuticals
NONE
NONE
NONE
NONE
Anthony Slavin is currently an employee of Abbvie Bioresearch Center and was formerly an employee of Boehringer INgelheim Pharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology and Program in Immunology (S.S.Z.), University of California, San Francisco; and Abbvie Bioresearch Center Inc. (A.J.S.), Worcester, MA.
- Correspondence to Dr. Zamvil: zamvil{at}ucsf.neuroimmunol.org
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto et al.Neurology, January 10, 2014 -
Article
Fulminant demyelinating encephalomyelitisInsights from antibody studies and neuropathologyFranziska Di Pauli, Romana Höftberger, Markus Reindl et al.Neurology - Neuroimmunology Neuroinflammation, November 04, 2015 -
Article
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonRussell C. Dale, Esther M. Tantsis, Vera Merheb et al.Neurology - Neuroimmunology Neuroinflammation, May 22, 2014 -
Views & Reviews
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al.Neurology, June 19, 2015